Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 1
2019 1
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar J, Williams H, Field TS, Manosalva A, Siddiqui M, Zafar A, Imoukhuede O, Hunter G, Demchuk AM, Mishra S, Gioia LC, Jalini S, Cayer C, Phillips S, Elamin E, Shoamanesh A, Subramaniam S, Kate M, Jacquin G, Camden MC, Benali F, Alhabli I, Bala F, Horn M, Stotts G, Hill MD, Gladstone DJ, Poppe A, Sehgal A, Zhang Q, Lethebe BC, Doram C, Ademola A, Shamy M, Kenney C, Sajobi TT, Swartz RH; AcT Trial Investigators. Menon BK, et al. Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29. Lancet. 2022. PMID: 35779553 Clinical Trial.
Cyclophosphamide treatment in active multiple sclerosis.
Gómez-Figueroa E, Gutierrez-Lanz E, Alvarado-Bolaños A, Casallas-Vanegas A, Garcia-Estrada C, Zabala-Angeles I, Cadena-Fernandez A, Veronica RA, Irene TF, Flores-Rivera J. Gómez-Figueroa E, et al. Among authors: alvarado bolanos a. Neurol Sci. 2021 Sep;42(9):3775-3780. doi: 10.1007/s10072-021-05052-1. Epub 2021 Jan 16. Neurol Sci. 2021. PMID: 33452657
Foix-Chavany-Marie Syndrome as a Manifestation of Unilateral Opercular Stroke.
Toledo-Trevino R, Manrique-Otero D, Castellanos-Pedroza E, Cano-Nigenda V, Alvarado-Bolaños A, Calleja-Castillo J, Arauz A. Toledo-Trevino R, et al. Among authors: alvarado bolanos a. Eur J Case Rep Intern Med. 2021 Apr 6;8(4):002462. doi: 10.12890/2021_002462. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33987126 Free PMC article.
Clinical experience of plasmapheresis for neuromyelitis optica patients in Mexico.
Gómez-Figueroa E, Alvarado-Bolaños A, García-Estrada C, Zabala-Ángeles I, Sánchez-Rosales N, Bribiesca-Contreras E, García-Alvarez G, Montes-Pérez Y, Ramos-Vega E, Casallas-Vanegas A, Carrillo-Loza K, Corona-Vázquez T, Rivas-Alonso V, Flores-Rivera J. Gómez-Figueroa E, et al. Among authors: alvarado bolanos a. Mult Scler Relat Disord. 2021 Jul;52:103022. doi: 10.1016/j.msard.2021.103022. Epub 2021 May 15. Mult Scler Relat Disord. 2021. PMID: 34034213
Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A, Cervantes-Arriaga A, Rodríguez-Violante M, Llorens-Arenas R, Calderón-Fajardo H, Millán-Cepeda R, Leal-Ortega R, Estrada-Bellmann I, Zuñiga-Ramírez C. Alvarado-Bolaños A, et al. J Neurol Sci. 2015 Nov 15;358(1-2):53-7. doi: 10.1016/j.jns.2015.08.010. Epub 2015 Aug 7. J Neurol Sci. 2015. PMID: 26276513
Determinants and impact of alexithymia on quality of life in Parkinson's disease.
Alvarado-Bolaños A, Cervantes-Arriaga A, Zuazua-Vidal L, Esquivel-Zapata Ó, Alcocer-Salas Á, Rodríguez-Violante M. Alvarado-Bolaños A, et al. Neurologia (Engl Ed). 2020 Dec 11:S0213-4853(20)30338-8. doi: 10.1016/j.nrl.2020.10.012. Online ahead of print. Neurologia (Engl Ed). 2020. PMID: 33317969 Free article. English, Spanish.
12 results